XOMA Initiates Gevokizumab Phase 2 Study for Moderate to Severe Acne Vulgaris Dec 21, 2011 8:00am EST
XOMA Secures Federal Contract to Expand Its Next-Generation Human Botulism Antitoxin Portfolio Oct 03, 2011 8:00am EDT
XOMA Announces Presentation and Webcast at Wedbush Securities 2011 Life Sciences Conference Aug 10, 2011 4:04pm EDT
